(Q40806642)

23 September 2017

title

Enhanced expression of basement-membrane-type heparan sulfate proteoglycan in tumor fibro-myxoid stroma of intrahepatic cholangiocarcinoma (English)

1 reference

heparan sulfate proteoglycans

23 September 2017

0 references

1 reference

Sabit H

1

1 reference

23 September 2017

Tsuneyama K

2

1 reference

23 September 2017

Shimonishi T

3

1 reference

23 September 2017

Harada K

4

1 reference

23 September 2017

Cheng J

5

1 reference

23 September 2017

Ida H

6

1 reference

23 September 2017

Saku T

7

1 reference

23 September 2017

Saito K

8

1 reference

23 September 2017

Nakanuma Y

9

1 reference

23 September 2017

publication date

1 April 2001

1 reference

23 September 2017

published in

Pathology International

1 reference

23 September 2017

volume

51

1 reference

23 September 2017

issue

4

1 reference

23 September 2017

page(s)

248-256

1 reference

Antisense targeting of perlecan blocks tumor growth and angiogenesis in vivo

23 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2001.01201.X

Biosynthesis of basement membrane molecules by salivary adenoid cystic carcinoma cells: an immunofluorescence and confocal microscopic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2001.01201.X

Heparan sulfate proteoglycans of the cardiovascular system. Specific structures emerge but how is synthesis regulated?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2001.01201.X

Characterization of proteoglycans synthesized by murine embryonal carcinoma cells (P19) reveals increased expression of perlecan (heparan sulfate proteoglycan) during neuronal differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2001.01201.X

Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2001.01201.X

Requirement of heparan sulfate for bFGF-mediated fibroblast growth and myoblast differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2001.01201.X

Syndecans, heparan sulfate proteoglycans, maintain the proteolytic balance of acute wound fluids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2001.01201.X

Relationship between interleukin-6 and proliferation and differentiation in cholangiocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2001.01201.X

Cholangiolocellular carcinoma of the liver.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2001.01201.X

Intracellular transport of basement membrane-type heparan sulphate proteoglycan in adenoid cystic carcinoma cells of salivary gland origin: an immunoelectron microscopic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2001.01201.X

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2001.01201.X

The biology of perlecan: the multifaceted heparan sulphate proteoglycan of basement membranes and pericellular matrices

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2001.01201.X

Increased expression of connective tissue growth factor in fibrotic human liver and in activated hepatic stellate cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2001.01201.X

Hepatic stellate cells: a target for the treatment of liver fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2001.01201.X

10.1046/J.1440-1827.2001.01201.X

21 January 2018

Identifiers

DOI

1 reference

23 September 2017

1 reference